세계의 메테나민 히푸레이트 정제 시장 보고서(2023년)

“Methenamine Hippurate Tablets Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on methenamine hippurate tablets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for methenamine hippurate tablets? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The methenamine hippurate tablets market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: 20 Tablets Or Bottle; 6 Tablets Or Bottle

• 2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

• 3) By Application: Uncomplicated UTIs; Healthcare-associated UTIs

• 4) By End User: Hospitals; Homecare; Specialty Clinics; Others End Users

• Companies Mentioned: Validus Pharmaceuticals LLC; Alvogen; Micro Labs USA Inc.; Aurobindo Pharma; Edenbridge Pharmaceuticals LLC

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the methenamine hippurate tablets market are Validus Pharmaceuticals LLC, Alvogen, Micro Labs USA Inc., Aurobindo Pharma, Edenbridge Pharmaceuticals LLC, Kreative Organics, CorePharma LLC, Amneal Pharmaceuticals Inc., Viatris Inc., County Line Pharmaceuticals, Mylan N.V., McKesson Corporation, Nuray Chemicals Private Limited, Chemische Fabrik Berg, and Siegfried AG.

The global methenamine hippurate tablets market is expected to grow from $8.34 billion in 2022 to $8.93 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The methenamine hippurate tablets market is expected to grow to $11.52 billion in 2027 at a CAGR of 6.6%.

The methenamine hippurate tablets market consists of sales of hexamine hippurate tablets, hiprex tablets, and urinary tract infection tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Methenamine hippurate tablets are used as a medicine to prevent or control recurring urinary tract infections caused by specific bacteria. It is not used for any other active infections.

North America was the largest region in the methenamine hippurate tablets market in 2022. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of methenamine hippurate tablets are 20 tablets or bottles and 6 tablets or bottles. The methenamine hippurate tablets are available to patients in the form of 20 tablets or a bottle. The distribution channels involved are hospital pharmacies, online pharmacies and retail pharmacies and applications include uncomplicated UTIs and healthcare-associated UTIs. The end users include hospitals, homecare, specialty clinics and others.

An increasing geriatric population is expected to boost the growth of the methenamine hippurate tablets market going forward. Geriatric population refers to the population of older people of 60 years and above. Geriatric patients are more vulnerable to urinary tract infections due to a variety of factors such as decreased urine flow, an enlarged prostate, or kidney stones, thus methenamine hippurate tablets are required to treat these conditions. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, one in six individuals on the planet will be 60 or older by 2030. In 2021, there were 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of persons who are 60 years or older globally will double by 2050 (2.1 billion). Between 2020 and 2050, the number of people who are 80 years or older is projected to treble, reaching 426 million. Therefore, the increasing geriatric population is driving the growth of the methenamine hippurate tablets market.

Product innovations have emerged as the key trend gaining popularity in the methenamine hippurate tablets market. Major companies operating in the methenamine hippurate tablets market are developing innovative products to strengthen their position in the market. For instance, in August 2021, Custex, a US-based urinary health brand, launched Cystex Ultra Protection. The unique features of Cystex Ultra Protection include probiotics, cranberries, vitamin A, and bio-shield technology. The Cystex Ultra Protection is intended to treat recurrent UTIs and maintain urinary tract health in more than 90% of women.

The rising cases of urinary tract infections are expected to boost the growth of the methenamine hippurate tablets market going forward. Urinary tract infections are common diseases that occur when bacteria enter the urethra and infect the urinary tract, usually through the skin or rectum. Methenamine hippurate tablets are used to prevent or treat recurring urinary tract infections caused by specific bacteria. For instance, according to Frontiers, a Switzerland-based media company, in 2021, around 5,870 urine tests were performed, with 2,070 of them being positive. Positive urine test results made up 35.26% of all urine tests. And, in 2020, 2,919 urine tests for 31,653 hospitalizations were performed. Therefore, rising cases of urinary tract infections are driving the growth of the methenamine hippurate market.

The countries covered in the methenamine hippurate tablets market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The methenamine hippurate tablets market research report is one of a series of new reports from The Business Research Company that provides methenamine hippurate tablets market statistics, including methenamine hippurate tablets industry global market size, regional shares, competitors with methenamine hippurate tablets market share, detailed methenamine hippurate tablets market segments, market trends, and opportunities, and any further data you may need to thrive in the methenamine hippurate tablets industry. This methenamine hippurate tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Methenamine Hippurate Tablets Market Characteristics

3. Methenamine Hippurate Tablets Market Trends And Strategies

4. Methenamine Hippurate Tablets Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Methenamine Hippurate Tablets Market
• 4.2. Ukraine-Russia War Impact On Methenamine Hippurate Tablets Market
• 4.3. Impact Of High Inflation On Methenamine Hippurate Tablets Market

5. Methenamine Hippurate Tablets Market Size And Growth

• 5.1. Global Methenamine Hippurate Tablets Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Methenamine Hippurate Tablets Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Methenamine Hippurate Tablets Market Segmentation

• 6.1. Global Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20 Tablets Or Bottle

6 Tablets Or Bottle

• 6.2. Global Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.3. Global Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Uncomplicated UTIs (Urinary Tract Infection)
• Healthcare-Associated UTIs (Urinary Tract Infection)
• 6.4. Global Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users

7. Methenamine Hippurate Tablets Market Regional And Country Analysis

• 7.1. Global Methenamine Hippurate Tablets Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Methenamine Hippurate Tablets Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Methenamine Hippurate Tablets Market

• 8.1. Asia-Pacific Methenamine Hippurate Tablets Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Methenamine Hippurate Tablets Market

• 9.1. China Methenamine Hippurate Tablets Market Overview
• 9.2. China Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Methenamine Hippurate Tablets Market

• 10.1. India Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Methenamine Hippurate Tablets Market

• 11.1. Japan Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Methenamine Hippurate Tablets Market

• 12.1. Australia Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Methenamine Hippurate Tablets Market

• 13.1. Indonesia Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Methenamine Hippurate Tablets Market

• 14.1. South Korea Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Methenamine Hippurate Tablets Market

• 15.1. Western Europe Methenamine Hippurate Tablets Market Overview
• 15.2. Western Europe Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Methenamine Hippurate Tablets Market

• 16.1. UK Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Methenamine Hippurate Tablets Market

• 17.1. Germany Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Methenamine Hippurate Tablets Market

• 18.1. France Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Methenamine Hippurate Tablets Market

• 19.1. Eastern Europe Methenamine Hippurate Tablets Market Overview
• 19.2. Eastern Europe Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Methenamine Hippurate Tablets Market

• 20.1. Russia Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Methenamine Hippurate Tablets Market

• 21.1. North America Methenamine Hippurate Tablets Market Overview
• 21.2. North America Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Methenamine Hippurate Tablets Market

• 22.1. USA Methenamine Hippurate Tablets Market Overview
• 22.2. USA Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Methenamine Hippurate Tablets Market

• 23.1. South America Methenamine Hippurate Tablets Market Overview
• 23.2. South America Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Methenamine Hippurate Tablets Market

• 24.1. Brazil Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Methenamine Hippurate Tablets Market

• 25.1. Middle East Methenamine Hippurate Tablets Market Overview
• 25.2. Middle East Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Methenamine Hippurate Tablets Market

• 26.1. Africa Methenamine Hippurate Tablets Market Overview
• 26.2. Africa Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Methenamine Hippurate Tablets Market Competitive Landscape And Company Profiles

• 27.1. Methenamine Hippurate Tablets Market Competitive Landscape
• 27.2. Methenamine Hippurate Tablets Market Company Profiles
  • 27.2.1. Validus Pharmaceuticals LLC
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Alvogen
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Micro Labs USA Inc.
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Aurobindo Pharma
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Edenbridge Pharmaceuticals LLC
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Methenamine Hippurate Tablets Market

29. Methenamine Hippurate Tablets Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer